Cannabinoid Receptor
Cannabinoid receptors are GPCRs that mediate the effects of endogenous cannabinoids (endocannabinoids) and phytocannabinoids, such as those found in cannabis. The two main types of cannabinoid receptors, CB1 and CB2, are involved in regulating a wide range of physiological processes, including pain perception, appetite, mood, and immune function. Cannabinoid receptor modulators have therapeutic potential in treating conditions such as chronic pain, epilepsy, and multiple sclerosis. At CymitQuimica, we offer a wide range of high-quality cannabinoid receptor modulators to support your research in neuropharmacology, pain management, and immunology.
Found 222 products for "Cannabinoid Receptor".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
CB2 receptor antagonist 2
Compound 39, also known as CB2 receptor antagonist 2, is a potent CB2 antagonist exhibiting an IC50 of 0.33 μM.Color and Shape:Odour SolidNervonoyl ethanolamide
CAS:Nervonoyl ethanolamide (NEA), an endogenous cannabinoid, functions as both a presynaptic and postsynaptic neuromodulator. Additionally, it is utilized in inflammation research [1].Formula:C26H51NO2Color and Shape:SolidMolecular weight:409.69GFB-024
GFB-024 is a humanized antibody targeting CB1, which can be used to study obesity.Color and Shape:LiquidMolecular weight:146.12 kDa (Predicted)CB1R antagonist 2
CB1R antagonist 2 (Compound 11g) functions as an antagonist of the cannabinoid receptor 1 (CB1R), inhibiting the MAPK/NF-κB signaling pathway and exhibiting anti-inflammatory properties. In RAW264.7 cells, it suppresses LPS-induced expression of IL-6, IL-1β, and TNF-α. In murine models, it improves OVA-induced allergic rhinitis.Formula:C24H26N4OColor and Shape:SolidMolecular weight:386.49RVD-Hpα
CAS:N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist.Formula:C65H105N19O17Purity:98%Color and Shape:SolidMolecular weight:1424.66Hemopressin(human, mouse) TFA
CAS:Hemopressin TFA: nonapeptide from hemoglobin, oral CB1 inverse agonist, eases inflammatory pain.Formula:C52H80F3N13O14Purity:98%Color and Shape:SolidMolecular weight:1168.27CB2R probe 1
CAS:CB2R Probe 1, a cannabinoid 2 receptor (CB2R) fluorescent probe, exhibits both safety and environmental friendliness, boasting a dissociation constant (K i) ofFormula:C36H42N4O4Color and Shape:SolidMolecular weight:594.74Docosahexaenoyl glycerol
CAS:Docosahexaenoyl glycerol, an analog of endocannabinoid, stimulates glucose uptake and exhibits anti-inflammatory efficacy [1] [2].Formula:C25H38O4Color and Shape:SolidMolecular weight:402.57Vicasinabin
CAS:Vicasinabin: potent CB2 agonist; researches chronic pain, atherosclerosis, bone mass, neuroinflammation.Formula:C15H22N10OColor and Shape:SolidMolecular weight:358.41Cannabicitran
CAS:Cannabicitran is a cannabinoid that can decrease rabbits intraocular pressure [1] [2].Formula:C21H30O2Color and Shape:SolidMolecular weight:314.46Zevaquenabant
CAS:Zevaquenabant (S-MRI-1867): oral CB1/iNOS antagonist combatting obesity-induced CKD.Formula:C25H21ClF3N5O2SColor and Shape:SolidMolecular weight:547.98Hemopressin (human, mouse)
CAS:Endogenous peptide, inhibits ep24.15/24.16/ACE with Ki of 27.76/3.43/1.87 μM. Lowers blood pressure, CB1 inverse agonist, reduces pain in vivo.Formula:C50H79N13O12Purity:98%Color and Shape:SolidMolecular weight:1054.26GPR55 agonist 4
GPR55 agonist 4 (Compound 28), with an EC50 of 131 nM for hGPR55 and 1.41 nM for rGPR55, effectively induces β-arrestin recruitment to human GPR55 [1].Formula:C19H16FN5O2Color and Shape:SolidMolecular weight:365.36TRPV1/CB2 agonist 1
TRPV1/CB2 agonist 1 (compound 41) is a dual agonist targeting hTRPV1 and CB2 receptors, with an EC50 value of 26.8 μM for hTRPV1. It is applicable in research related to the nervous system.Color and Shape:Odour Solid(±)5(6)-EET Ethanolamide
(±)5(6)-EET Ethanolamide is a metabolite derived from Anandamide through oxidation by cytochrome P450 enzymes. It acts as a selective cannabinoid receptor 2 (CB2) agonist. The Ki values for (±)5(6)-EET Ethanolamide against human CB1 and CB2 are 11.4 μM and 8.9 nM, respectively. This compound can be used in studies related to immunoregulation and neuroinflammation.N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide
CAS:N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide: binds CB1 (Ki=365 nM), activates PPARα (EC50=698 nM), reduces rat food intake, no FAAH inhibition.Formula:C27H45NO3Color and Shape:SolidMolecular weight:431.661HU-308
CAS:HU-308, a synthetic cannabinoid analogue, is a highly selective agonist of the CB2 receptor. It demonstrates an affinity for the CB2 receptor that is over 440 times greater than its affinity for the CB1 receptor, which are predominantly found in immune cells. This compound plays a crucial role in modulating the immunosuppressive effects of the endocannabinoid system (ECS). Additionally, HU-308 possesses anti-inflammatory and neuroprotective properties, and it regulates the function of microglia. Its potential applications include research into neuroinflammation and retinal diseases.Formula:C27H42O3Color and Shape:SolidMolecular weight:414.62CB1-IN-3
CB1-IN-3 (Compound 6i) is a potent inhibitor of the cannabinoid receptor type 1 (CB1). It holds potential for research in obesity, inflammation, and neurological disorders.Color and Shape:Odour Solid(R)-Zevaquenabant
(R)-Zevaquenabant ((R)-MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS). It is beneficial in improving chronic kidney disease (CKD) caused by obesity.Color and Shape:Odour SolidCB2R/FAAH modulator-2
CAS:CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH.Formula:C24H33NO2Purity:99.15%Color and Shape:SolidMolecular weight:367.5243
